Fibroblast growth factor receptors (FGFRs) are critical drivers of oncogenesis in various solid tumors, including urothelial carcinoma, hepatocellular carcinoma, ovarian cancer and lung adenocarcinoma ...
Insilico Medicine (“Insilico”) announces that the team, with the support of its generative chemistry engine, has developed a ...
A diagnostic for FGFR2 mutations from Nihon Stery has also been approved for use alongside the drug treatment. Tasfygo was given a priority review in Japan, reflecting the relatively high ...
2014年12月， 复旦大学附属肿瘤医院 在Oncotarget期刊上发表了一篇论文。在 发表4年后 ，因 图片组内重复 在pubpeer上被读者质疑。 论文题为 “Multiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor ...
Expression of Trop2, Nectin-4, and FOLR1 cell surface markers in biliary tract cancers: Is it time to repurpose drugs? This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback